Literature DB >> 18618022

Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice.

Meizi Jiang1, Hideaki Bujo, Kenji Ohwaki, Hiroyuki Unoki, Hiroyuki Yamazaki, Tatsuro Kanaki, Manabu Shibasaki, Kazuhiko Azuma, Kenichi Harigaya, Wolfgang J Schneider, Yasushi Saito.   

Abstract

Medial-to-intimal migration of SMCs is critical to atherosclerotic plaque formation and remodeling of injured arteries. Considerable amounts of the shed soluble form of the LDL receptor relative LR11 (sLR11) produced by intimal SMCs enhance SMC migration in vitro via upregulation of urokinase-type plasminogen activator receptor (uPAR) expression. Here, we show that circulating sLR11 is a novel marker of carotid intima-media thickness (IMT) and that targeted disruption of the LR11 gene greatly reduces intimal thickening of arteries through attenuation of Ang II-induced migration of SMCs. Serum concentrations of sLR11 were positively correlated with IMT in dyslipidemic subjects, and multivariable regression analysis suggested sLR11 levels as an index of IMT, independent of classical atherosclerosis risk factors. In Lr11-/- mice, femoral artery intimal thickness after cuff placement was decreased, and Ang II-stimulated migration and attachment of SMCs from these mice were largely abolished. In isolated murine SMCs, sLR11 caused membrane ruffle formation via activation of focal adhesion kinase/ERK/Rac1 accompanied by complex formation between uPAR and integrin alphavbeta3, a process accelerated by Ang II. Overproduction of sLR11 decreased the sensitivity of Ang II-induced activation pathways to inhibition by an Ang II type 1 receptor blocker in mice. Thus, we demonstrate a requirement for sLR11 in Ang II-induced SMC migration and propose what we believe is a novel role for sLR11 as a biomarker of carotid IMT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18618022      PMCID: PMC2447934          DOI: 10.1172/JCI32381

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

Review 1.  Lipoprotein receptors in the vascular wall.

Authors:  Joachim Herz; David Y Hui
Journal:  Curr Opin Lipidol       Date:  2004-04       Impact factor: 4.776

Review 2.  Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.

Authors:  Ute Reuning; Viktor Magdolen; Sandra Hapke; Manfred Schmitt
Journal:  Biol Chem       Date:  2003-08       Impact factor: 3.915

3.  Loss of apolipoprotein E receptor LR11 in Alzheimer disease.

Authors:  Clemens R Scherzer; Katrin Offe; Marla Gearing; Howard D Rees; Guofu Fang; Craig J Heilman; Chica Schaller; Hideaki Bujo; Allan I Levey; James J Lah
Journal:  Arch Neurol       Date:  2004-08

4.  LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration.

Authors:  Yanjuan Zhu; Hideaki Bujo; Hiroyuki Yamazaki; Kenji Ohwaki; Meizi Jiang; Satoshi Hirayama; Tatsuro Kanaki; Manabu Shibasaki; Kazuo Takahashi; Wolfgang J Schneider; Yasushi Saito
Journal:  Circ Res       Date:  2004-02-05       Impact factor: 17.367

Review 5.  Low density lipoprotein receptor-related protein: regulation of the plasma membrane proteome.

Authors:  Steven L Gonias; Lihua Wu; Ana Maria Salicioni
Journal:  Thromb Haemost       Date:  2004-06       Impact factor: 5.249

6.  Mutant oocytic low density lipoprotein receptor gene family member causes atherosclerosis and female sterility.

Authors:  H Bujo; T Yamamoto; K Hayashi; M Hermann; J Nimpf; W J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

7.  Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration.

Authors:  A Wayne Orr; Carrie A Elzie; Dennis F Kucik; Joanne E Murphy-Ullrich
Journal:  J Cell Sci       Date:  2003-07-15       Impact factor: 5.285

8.  LRP1B attenuates the migration of smooth muscle cells by reducing membrane localization of urokinase and PDGF receptors.

Authors:  Kousei Tanaga; Hideaki Bujo; Yanjuan Zhu; Tatsuro Kanaki; Satoshi Hirayama; Kazuo Takahashi; Masahiro Inoue; Keiji Mikami; Wolfgang J Schneider; Yasushi Saito
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-05-27       Impact factor: 8.311

9.  Regulation of Rac1 activation by the low density lipoprotein receptor-related protein.

Authors:  Zhong Ma; Keena S Thomas; Donna J Webb; Radim Moravec; Ana Maria Salicioni; Wendy M Mars; Steven L Gonias
Journal:  J Cell Biol       Date:  2002-12-23       Impact factor: 10.539

10.  Chicken oocyte growth is mediated by an eight ligand binding repeat member of the LDL receptor family.

Authors:  H Bujo; M Hermann; M O Kaderli; L Jacobsen; S Sugawara; J Nimpf; T Yamamoto; W J Schneider
Journal:  EMBO J       Date:  1994-11-01       Impact factor: 11.598

View more
  15 in total

1.  Soluble SORLA Enhances Neurite Outgrowth and Regeneration through Activation of the EGF Receptor/ERK Signaling Axis.

Authors:  Jessica Stupack; Xiao-Peng Xiong; Lu-Lin Jiang; Tongmei Zhang; Lisa Zhou; Alex Campos; Barbara Ranscht; William Mobley; Elena B Pasquale; Huaxi Xu; Timothy Y Huang
Journal:  J Neurosci       Date:  2020-06-29       Impact factor: 6.167

2.  Vitreous fluid and circulating levels of soluble lr11, a novel marker for progression of diabetic retinopathy.

Authors:  Tomoaki Shiba; Hideaki Bujo; Mao Takahashi; Yukihiro Sato; Meizi Jiang; Yuichi Hori; Takatoshi Maeno; Kohji Shirai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-08       Impact factor: 3.117

3.  Self-pMHCII complexes are variably expressed in the thymus and periphery independent of mRNA expression but dependent on the activation state of the APCs.

Authors:  Stephanie N Rodriguez; Meizi Jiang; Hideaki Bujo; Paul M Allen
Journal:  Mol Immunol       Date:  2014-10-22       Impact factor: 4.407

Review 4.  Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease.

Authors:  Miki Nagase; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2013-01-08       Impact factor: 28.314

5.  Soluble form of LR11 is highly increased in the vitreous fluids of patients with idiopathic epiretinal membrane.

Authors:  Ryuya Hashimoto; Meizi Jiang; Tomoaki Shiba; Nobuyuki Hiruta; Mao Takahashi; Morihiro Higashi; Yuichi Hori; Hideaki Bujo; Takatoshi Maeno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-01-19       Impact factor: 3.117

6.  Inhibition of Endocytosis of Clathrin-Mediated Angiotensin II Receptor Type 1 in Podocytes Augments Glomerular Injury.

Authors:  Kazunori Inoue; Xuefei Tian; Heino Velazquez; Keita Soda; Zhen Wang; Christopher E Pedigo; Ying Wang; Elizabeth Cross; Marwin Groener; Jee-Won Shin; Wei Li; Hossam Hassan; Koichi Yamamoto; Peter Mundel; Shuta Ishibe
Journal:  J Am Soc Nephrol       Date:  2019-09-11       Impact factor: 10.121

7.  The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinase-type plasminogen activator receptor (uPAR)-mediated adhesion of immature hematological cells.

Authors:  Keigo Nishii; Chiaki Nakaseko; Meizi Jiang; Naomi Shimizu; Masahiro Takeuchi; Wolfgang J Schneider; Hideaki Bujo
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

Review 8.  Apolipoprotein E receptors in the nervous system.

Authors:  Joachim Herz
Journal:  Curr Opin Lipidol       Date:  2009-06       Impact factor: 4.776

9.  Cholesterol-related gene variants are associated with diabetes in coronary artery disease patients.

Authors:  Aybike Sena Ozuynuk; Aycan Fahri Erkan; Berkay Ekici; Nihan Erginel-Unaltuna; Neslihan Coban
Journal:  Mol Biol Rep       Date:  2021-05-21       Impact factor: 2.316

10.  Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes.

Authors:  Shokichi Tsukamoto; Masahiro Takeuchi; Takeharu Kawaguchi; Emi Togasaki; Atsuko Yamazaki; Yasumasa Sugita; Tomoya Muto; Shio Sakai; Yusuke Takeda; Chikako Ohwada; Emiko Sakaida; Naomi Shimizu; Keigo Nishii; Meizi Jiang; Koutaro Yokote; Hideaki Bujo; Chiaki Nakaseko
Journal:  Exp Mol Med       Date:  2014-04-04       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.